Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 04:05 pm EDT
Fresh Tracks Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 0.053 million compared to USD 4.32 million a year ago. Net loss was USD 2.28 million compared to USD 1.15 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.43 a year ago.
For the six months, revenue was USD 0.062 million compared to USD 4.41 million a year ago. Net loss was USD 6.56 million compared to USD 10.56 million a year ago. Basic loss per share from continuing operations was USD 1.36 compared to USD 3.98 a year ago.